Company Overview - A beverages company is rebranding from Safety Shot, Inc. to Bonk, Inc. and will trade under the ticker BNKK, aiming to provide clarity about its brand and evolve its plans [1] - The company has increased its Bonk (BONK) holdings to 2.7% of the circulating supply, valued at approximately $43 million, with a goal to reach 5% by year-end [1] Strategic Focus - Bonk, Inc. is shifting its focus to the digital asset space, consolidating various Bonk projects and revenue streams into a single publicly investable entity [2] - The firm is exploring alternative methods to produce yield on its holdings, as it does not have a native staking feature [4] Market Performance - The company's stock, still trading under the SHOT ticker, has seen a nearly 38% increase over the past five days but is down more than 3% over the past month [3] - Bonk, Inc. is part of a broader trend of digital asset treasury companies, with notable competitors like Michael Saylor's Strategy, which holds over $77 billion in Bitcoin [3] Product Development - Bonk, Inc. is looking to invest in products that enhance the Solana ecosystem, having already acquired a 10% revenue share in the meme coin launchpad LetsBonk [5] - The Bonk token has evolved from a meme coin to a project that creates important tools for the Solana network, including a trading bot and an automatic market maker [4]

Core Insights - Safety Shot, Inc. has received its first revenue share payment of $500,000 from its 10% interest in letsBONK.fun and plans to reinvest this into acquiring more BONK tokens [2][5] - The company aims to increase its holdings of BONK to 5% of the total circulating supply by the end of 2025, currently holding over 2.7% [1][5] - The strategy involves leveraging a non-dilutive revenue stream to accumulate BONK tokens during a market downturn, taking advantage of perceived discounts [3][5] Financial Performance - The company anticipates an additional revenue share payment of approximately $650,000 within the next 27 days [2] - The strong, debt-free balance sheet allows the company to act decisively in acquiring digital assets [3][5] Market Strategy - Historically, the fourth quarter, especially October and November, has seen significant price appreciation for the BONK token, positioning the company to capitalize on seasonal trends [4][5] - The approach aims to create a powerful flywheel for shareholder value by systematically growing the digital asset treasury using operational revenue [5] Company Overview - Safety Shot, Inc. is focused on bridging traditional public markets with the digital asset ecosystem, particularly through revenue-generating assets in the DeFi space [6]

Key Points - Top KingWin Ltd (NASDAQ: WAI) shares increased by 87.4% to $5.92 in pre-market trading after announcing a sales contract with Walker Times International for 10,000 units of TK-D2C AI Robots [1] - MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) saw a significant rise of 242% to $4.96 in pre-market trading due to plans to double the installation of its Authentication Device "Orb" to 200 stores in collaboration with "World" [5] - New Era Energy & Digital, Inc. (NYSE: NUAI) surged 37.6% to $1.90 in pre-market trading after a previous 50% increase [5] - Datavault AI Inc. (NASDAQ: DVLT) gained 33% to $1.11 in pre-market trading after securing a $150 million investment in Bitcoin to build a supercomputer [5] - Harrison Global Holdings Inc. (NASDAQ: BLMZ) increased by 28.3% to $0.2288 in pre-market trading [5] - Lexaria Bioscience Corp. (NASDAQ: LEXX) rose 28.1% to $1.96 in pre-market trading after ending its "Capital on Demand" Sales Agreement with JonesTrading Institutional Services LLC [5] - Safety Shot, Inc. (NASDAQ: SHOT) gained 14.8% to $0.2868 in pre-market trading following a partnership with Monarq Asset Management [5] - Diginex Limited (NASDAQ: DGNX) jumped 13.6% to $15.00 in pre-market trading after a previous decline of 16% [5] - GLOBALFOUNDRIES Inc. (NASDAQ: GFS) increased by 9.9% to $36.09 in pre-market trading [5] - American Rebel Holdings, Inc. (NASDAQ: AREB) surged 9.7% to $1.13 after announcing a 1-for-20 reverse stock split [5] - Kuke Music Holding Limited (NYSE: KUKE) dipped 30.5% to $0.8200 after acquiring a controlling interest in Naxos Music Group [5] - Wellgistics Health, Inc. (NASDAQ: WGRX) fell 24.3% to $0.7598 after announcing a $5 million public offering [5] - Wolfspeed, Inc. (NYSE: WOLF) shares decreased by 24% to $1.41 after a decline of around 17% on Thursday [5] - Concentrix Corporation (NASDAQ: CNXC) declined 20.5% to $43.73 after reporting worse-than-expected third-quarter adjusted EPS results and cutting FY25 adjusted EPS guidance [5] - DarioHealth Corp. (NASDAQ: DRIO) fell 18.9% to $11.10 after a previous jump of 44% following a strategic review [5] - N2OFF, Inc. (NASDAQ: NITO) declined 13.7% to $4.75 after stockholders approved the acquisition of MitoCareX Bio [5] - Legacy Education Inc. (NYSE: LGCY) fell 13.3% to $10.68 after reporting worse-than-expected fourth-quarter EPS results [5] - Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) dipped 9.5% to $20.12 in pre-market trading [5] - Pharming Group N.V. (NASDAQ: PHAR) fell 9.1% to $13.45 in pre-market trading [5] - Kingsoft Cloud Holdings Limited (NASDAQ: KC) decreased by 7.5% to $16.15 after announcing the pricing of an upsized HK$2,802 million offering of new shares [5]

Core Insights - Several small-cap stocks experienced significant gains in after-hours trading due to corporate updates, clinical developments, and strategic shifts Company Summaries MEDIROM Healthcare Technologies Inc. (MRM) - Shares surged 282.8% to $5.55 after announcing plans to double the installation of its biometric authentication device "Orb" to 200 stores in collaboration with "World" [2] - Closed at $1.45 during regular trading, down 7.05%, with a trading volume of over 31.5 million shares [3] - The stock has a 52-week range of $0.34 to $5.30, highlighting the scale of its overnight move [3] Lexaria Bioscience Corp. (LEXX) - Shares rose 45.75% to $2.23 following renewed interest in its DehydraTECH drug delivery platform, which enhances GLP-1 drug delivery [4] - Closed at $1.53, up 7.75%, with a volume exceeding 7.5 million shares [5] - The stock's 52-week range is $0.775 to $3.392, with Thursday's close near the midpoint [5] Safety Shot, Inc. (SHOT) - Shares increased 12% to $0.28 after announcing a partnership with Monarq Asset Management to manage its BONK Holdings Treasury [6] - Closed at $0.25, down 9.06%, with a trading volume of over 15.4 million shares [7] - The stock has a 52-week range of $0.23 to $1.35, with the after-hours price near the lower end [7] Aquestive Therapeutics, Inc. (AQST) - Shares rose 11.41% to $5.86 following favorable regulatory news regarding its oral epinephrine candidate, Anaphylm [8] - Closed at $5.26, down 2.95%, with a volume of over 3.6 million shares [9] - The stock's 52-week range is $2.12 to $6.00, with the after-hours price near the upper end [9] Ovid Therapeutics Inc. (OVID) - Shares increased 4.26% to $1.47 after reaching a 52-week high during regular trading, driven by progress in its neurological pipeline [10] - Closed at $1.41, up 0.71%, with a trading volume of over 2.4 million shares [11] - The stock has a 52-week range of $0.2430 to $1.47, with Thursday's close at the top end of its recent performance band [11]

Industry Overview - Biotech and healthcare stocks are responding positively to clinical trial progress, regulatory developments, and economic indicators, particularly with the Federal Reserve's first rate cut of 2025, which is expected to improve funding conditions for capital-intensive sectors like biotechnology [1] Company Highlights - **Sonnet BioTherapeutics Holdings Inc. (SONN)**: Shares increased by 11.19% in after-hours trading, reaching $7.85 after a regular session close of $7.06. The stock has a 52-week range of $1.08 - $19.30. The company expanded clinical evaluation of its lead candidate, SON-1010, for ovarian cancer, reporting a strong safety profile and a partial response at the highest dose level [2][3] - **Akari Therapeutics Plc (AKTX)**: Shares surged 11.58% in after-hours trading to $0.8855 after closing at $0.7936. The stock has a 52-week range of $0.5710 - $3.8500. The increase follows a provisional patent filing for its antibody-drug conjugate platform aimed at cancer treatment, which is expected to enhance its intellectual property and support the development of first-in-class ADCs [4][5] - **Safety Shot Inc. (SHOT)**: Shares rose 9.75% in after-hours trading to $0.3333 after closing at $0.3037. The company announced a strategic refresh of its Board of Directors with three new members to strengthen its capabilities in digital assets and operations [6][7] - **Reviva Pharmaceuticals Holdings Inc. (RVPH)**: Shares climbed 10.09% in after-hours trading to $0.4451 after closing at $0.4043. The stock has a 52-week range of $0.3000 - $4.2800. The price movement follows a revised analyst rating maintaining a "Speculative Buy" while lowering the price target from $14.00 to $7.00. Reviva's lead candidate, brilaroxazine, is being developed for multiple neuropsychiatric and respiratory indications [8][9][10] - **Cognition Therapeutics Inc. (CGTX)**: Shares rose 7.48% in after-hours trading to $1.58 after closing down at $1.47. The company is focused on its lead candidate, Zervimesine, for Alzheimer's disease, and recently closed a $30 million offering to support its Phase 3 development [12][13]

Group 1 - Solana's price increased by 2% on Thursday, surpassing $228 for the first time since February 2025, driven by capital inflows from MOGU, a China-based fashion brand allocating up to $20 million to digital currencies [1] - The trend of corporate crypto adoption is accelerating globally, with notable examples including MOGU and Nasdaq-listed Safety Shot forming BONK Holdings LLC to pursue a digital asset strategy [2] - Safety Shot's new subsidiary has invested $5 million in Solana's BONK, raising its total treasury to over $63 million [3] Group 2 - The 2% gain on Thursday was the lowest daily increase of the week, following four consecutive days of profit since trading began at $200 on Sunday, indicating potential profit-taking among investors [4] - A golden cross signal on Solana's daily chart suggests a sustained bullish trend, with a 14% gain over four days since the formation, and the RSI near 65 indicates room for further gains [5] - Solana is currently trading at $226, above the initial support level of $217, with potential targets of $240 and $250 if consolidation above $220 continues [6] - Increased trading volume, up 4% intraday, may encourage speculative traders to enter long positions, capitalizing on fresh corporate demand that has yet to be fully priced in [7]

Group 1 - Safety Shot, Inc. announced the establishment of a wholly-owned subsidiary, BONK Holdings LLC, to advance its digital asset strategy [1] - BONK Holdings has acquired a total of 228.9 billion BONK tokens through two previous funding rounds and a $5 million acquisition in partnership with FalconX, representing over 2.5% of the total circulating supply [1] - The current value of BONK Holdings' holdings is approximately $55 million [1]

My lord....My money was ona Solana Treasury company happening and flows going thereSeems BONK front ran it lolBONK treasury company before SOL treasury company, complete.CoinGecko (@coingecko):NEWS: Safety Shot Inc. ($SHOT), a Nasdaq-listed health beverage company, is pivoting to become a $BONK memecoin treasury.Here's what's happening 👇 https://t.co/Xiyfgm727r ...

NEWS: Safety Shot Inc. ($SHOT), a Nasdaq-listed health beverage company, is pivoting to become a $BONK memecoin treasury.Here's what's happening 👇 https://t.co/Xiyfgm727r ...

Company Performance - Monday.com (MNDY) shares dipped around 27% after posting second-quarter results, despite reporting a quarterly revenue growth of 27% year-on-year to $299.01 million, which beat the analyst consensus estimate of $293.54 million [2] - The adjusted EPS of Monday.com was $1.09, surpassing the analyst consensus estimate of 86 cents [2] - For fiscal third-quarter 2025, Monday.com expects revenue between $311.00 million and $313.00 million, slightly above the analyst consensus estimate of $312.95 million, with an adjusted operating margin of 11%-12% [3] Market Movements - Equillium, Inc. (EQ) shares surged 115% to $1.0650 after announcing up to $50 million in financing through a securities purchase agreement [9] - TEGNA Inc. (TGNA) shares rose 29% to $19.67 following reports of Nexstar's acquisition talks [9] - International Money Express, Inc. (IMXI) shares increased by 63% to $15.08 after Western Union announced plans to acquire Intermex for $500 million [9] - Owens & Minor, Inc. (OMI) shares fell 25% to $5.29 due to worse-than-expected second-quarter earnings [9] - Thumzup Media Corporation (TZUP) shares dropped 34% to $10.25 after announcing a $50 million confidentially marketed public offering at $10 per share [9] - Safety Shot, Inc. (SHOT) shares decreased by 44% to $0.6388 following a strategic alliance announcement [9]